Related Experiment Video
Updated: Aug 16, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Abstract:
Because of problems of penicillin allergy or lack of veins for intravenous administration of antibiotics, nine patients with endocarditis were treated with clindamycin, administered intramuscularly. Five patients were heroin addicts with staphylococcal endocarditis and four had alpha-streptococcal endocarditis. The only therapeutic failure occurred in a patient with a strain of Staphylococcus aureus that became resistant to clindamycin in vivo. Such resistance has been reported to occur in vitro, and testing for it should prove useful in proper selection of cases for treatment with clindamycin, an agent that appears to be effective in selected cases of endocarditis.
Insights
Intramuscular clindamycin effectively treated endocarditis in most patients when penicillin allergy or IV access was an issue. Testing for Staphylococcus aureus resistance to clindamycin is recommended for optimal treatment selection.
Area of Science:
- Infectious Diseases
- Pharmacology
- Cardiology
Background:
- Endocarditis poses significant treatment challenges, particularly for patients with penicillin allergies or limited intravenous access.
- Alternative antibiotic administration routes and agents are crucial for managing complex endocarditis cases.
Purpose of the Study:
- To evaluate the efficacy and safety of intramuscular clindamycin for treating endocarditis in patients unsuitable for standard therapies.
- To assess the development of antimicrobial resistance during clindamycin treatment.
Main Methods:
- Nine patients with endocarditis received intramuscular clindamycin.
- Patient cohorts included those with staphylococcal endocarditis (n=5) and alpha-streptococcal endocarditis (n=4).
- Clinical outcomes and development of resistance were monitored.
Main Results:
- Clindamycin demonstrated therapeutic success in the majority of patients.
- One patient with Staphylococcus aureus endocarditis experienced treatment failure due to in vivo development of clindamycin resistance.
- No other adverse events or treatment failures were reported.
Conclusions:
- Intramuscular clindamycin is a viable treatment option for selected endocarditis cases, especially when penicillin allergy or IV access is problematic.
- Pre-treatment in vitro testing for clindamycin resistance in Staphylococcus aureus strains is advisable to ensure treatment efficacy.
- Further research into antimicrobial resistance patterns is warranted for optimizing antibiotic selection in endocarditis.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Streptococcal Pharyngitis

